Satellos Bioscience Inc. (MSCL.TO)
CAD 0.89
(-4.3%)
CAD 0.89
(-4.3%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -8.81 Million CAD | -136.13% |
| 2022 | -3.73 Million CAD | -3013.77% |
| 2021 | -119.91 Thousand CAD | -149.0% |
| 2020 | -48.16 Thousand CAD | 96.17% |
| 2019 | -1.25 Million CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -5.93 Million CAD | -65.63% |
| 2024 Q2 | -3000.00 CAD | 99.95% |
| 2023 Q3 | -2.73 Million CAD | -211.32% |
| 2023 FY | -8.81 Million CAD | -136.13% |
| 2023 Q2 | -878.21 Thousand CAD | 5.87% |
| 2023 Q1 | -933 Thousand CAD | 8.44% |
| 2023 Q4 | -3.58 Million CAD | -31.13% |
| 2022 Q4 | -1.01 Million CAD | -13.47% |
| 2022 FY | -3.73 Million CAD | -3013.77% |
| 2022 Q3 | -898 Thousand CAD | 0.0% |
| 2021 FY | -119.91 Thousand CAD | -149.0% |
| 2020 FY | -48.16 Thousand CAD | 96.17% |
| 2019 FY | -1.25 Million CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Appili Therapeutics Inc. | 813.74 Thousand CAD | 1183.509% |
| Eupraxia Pharmaceuticals Inc. | -209.91 Thousand CAD | -4100.352% |
| Helix BioPharma Corp. | -14 Thousand CAD | -62878.571% |
| Microbix Biosystems Inc. | 7.48 Million CAD | 217.853% |
| Medicenna Therapeutics Corp. | -5000.00 CAD | -176240.0% |
| Oncolytics Biotech Inc. | -403 Thousand CAD | -2087.841% |
| Sernova Corp. | -445.55 Thousand CAD | -1878.898% |